1
40
4
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
273–274
Issue
3
Volume
5
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Cutaneous effects of sirolimus in renal transplant recipients.
Publisher
An entity responsible for making the resource available
Journal of drugs in dermatology : JDD
Date
A point or period of time associated with an event in the lifecycle of the resource
2006
2006-03
Subject
The topic of the resource
Humans; Immunosuppressive Agents/*adverse effects; *Kidney Transplantation; Drug Eruptions/*etiology; Sirolimus/*adverse effects
Creator
An entity primarily responsible for making the resource
Warino Lindsey; Libecco James
Description
An account of the resource
Cancer is a major cause of death in immunosuppressed transplant patients. Therefore, sirolimus is frequently used in these patients for its immunosuppressive and antineoplastic properties. However, a variety of cutaneous side effects have resulted from sirolimus therapy. Consequently, dermatologists must be aware of such adverse events and understand the risks and benefits of discontinuing therapy.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Kidney Transplantation
2006
Department of Family & Community Medicine
Department of Internal Medicine
Drug Eruptions/*etiology
Humans
Immunosuppressive Agents/*adverse effects
Journal of drugs in dermatology : JDD
Libecco James
NEOMED College of Medicine
Sirolimus/*adverse effects
Warino Lindsey
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
577–579
Issue
6
Volume
8
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Painful parotid hypertrophy with bulimia: a report of medical management.
Publisher
An entity responsible for making the resource available
Journal of drugs in dermatology : JDD
Date
A point or period of time associated with an event in the lifecycle of the resource
2009
2009-06
Subject
The topic of the resource
Adult; Female; Humans; Hypertrophy; Bulimia/*complications; Hyperamylasemia/etiology; Pain/drug therapy/*physiopathology; Parotid Gland/*pathology/physiopathology; Pilocarpine/*therapeutic use; Sublingual Gland/pathology
Creator
An entity primarily responsible for making the resource
Park Kelly K; Tung Rebecca C; de Luzuriaga Arlene Ruiz
Description
An account of the resource
In eating disorders, such as bulimia nervosa, body image disturbance often extends beyond the realm of weight and shape into the dermatologic spectrum. While commonly associated conditions due to binging and self-induced vomiting include cutaneous entities (e.g., Russell's sign, acne, alopecia and hypertrichosis) and oral pathologies (e.g., enamel erosion, caries and mild parotid hypertrophy), a rare but troubling manifestation is disfiguring parotid enlargement (sialoadenomegaly). This article presents a case of painful sialoadenomegaly associated with hyperamylasemia in a bulimic patient successfully managed with pilocarpine.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2009
Adult
Bulimia/*complications
de Luzuriaga Arlene Ruiz
Female
Humans
Hyperamylasemia/etiology
Hypertrophy
Journal of drugs in dermatology : JDD
Pain/drug therapy/*physiopathology
Park Kelly K
Parotid Gland/*pathology/physiopathology
Pilocarpine/*therapeutic use
Sublingual Gland/pathology
Tung Rebecca C
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
1429–1431
Issue
11
Volume
9
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Blue foot: a second case of "tattoo blow-out" pigment spread successfully treated with the QS-Nd:YAG laser.
Publisher
An entity responsible for making the resource available
Journal of drugs in dermatology : JDD
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-11
Subject
The topic of the resource
Adult; Female; Humans; *Foot; *Laser Therapy; Tattooing/*adverse effects; Lasers; Solid-State/*therapeutic use
Creator
An entity primarily responsible for making the resource
Khetarpal Shilpi; Molenda Matthew; Seiger Eric; Pui John; Obagi Suzan
Description
An account of the resource
The "tattoo blow-out" phenomenon occurs when tattoo pigments spread outside the border of a tattoo. It is thought to occur when ink is injected too deeply. A healthy 36-year-old female presented to a dermatologist with diffuse spread of tattoo pigment outside the original tattoo that occurred within one day of the placement of a professional tattoo on the dorsum of her foot. The patient was seeking treatment six weeks after the tattoo was placed because she thought the discoloration would improve or resolve on its own, but it worsened. Two punch biopsies were obtained for histology. The biopsy results confirmed granular black pigment consistent with a tattoo in the dermis and subcutaneous fat. The location of pigment was deeper than expected. Due to the success of the QS-Nd:YAG laser in a prior patient, the same treatment was recommended for this patient. The patient received nine laser sessions using the Q-switched laser at 1064 nm, 4 mm, 10 Hz, with gradually increasing energy from 4.5 to 6.0 J/cm2. The pigment outside of the original tattoo borders faded and is barely perceptible. It is important that physicians be made aware of tattoo complications so they can advise patients in regards to the associated risks.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Foot
*Laser Therapy
2010
Adult
Female
Humans
Journal of drugs in dermatology : JDD
Khetarpal Shilpi
Lasers
Molenda Matthew
Obagi Suzan
Pui John
Seiger Eric
Solid-State/*therapeutic use
Tattooing/*adverse effects
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
63–67
Issue
1
Volume
2
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Local blistering reaction complicating subcutaneous injection of pegylated interferon in a patient with hepatitis C.
Publisher
An entity responsible for making the resource available
Journal of drugs in dermatology : JDD
Date
A point or period of time associated with an event in the lifecycle of the resource
2003
2003-01
Subject
The topic of the resource
Humans; Male; Middle Aged; Recombinant Proteins; *Interferon-alpha/*administration & dosage/*adverse effects; *Polyethylene Glycols; Blister/*chemically induced/pathology; Hepatitis C/*drug therapy; Interferon alpha-2; Injections; Subcutaneous
Creator
An entity primarily responsible for making the resource
Gallina Kelly; Brodell Robert T; Naffah Farid; Nedorost Susan
Description
An account of the resource
PEG-Intron is a covalent conjugate of recombinant alpha-2b interferon with monomethoxy polyethylene glycol (PEG). Compared to standard interferon-alpha injections, this preparation has a longer half-life allowing for once-weekly injections and superior antiviral efficacy in the treatment of hepatitis C when used in combination with ribavirin. We report the first case of a local blistering reaction developing in a patient receiving pegylated interferon-alpha-2b. Previous reports of local cutaneous reactions to standard and pegylated interferon-alpha are reviewed and the pathophysiological mechanisms are discussed.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Interferon-alpha/*administration & dosage/*adverse effects
*Polyethylene Glycols
2003
Blister/*chemically induced/pathology
Brodell Robert T
Gallina Kelly
Hepatitis C/*drug therapy
Humans
Injections
Interferon alpha-2
Journal of drugs in dermatology : JDD
Male
Middle Aged
Naffah Farid
Nedorost Susan
Recombinant Proteins
Subcutaneous